IRMD vs. SYK

Last updated Apr 2, 2026

Compare and contrast key facts about IRadimed Corporation (IRMD) and Stryker Corporation (SYK).

Performance

IRMD vs. SYK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IRadimed Corporation (IRMD) and Stryker Corporation (SYK). The values are adjusted to include any dividend payments, if applicable.

IRMD vs. SYK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IRMD IRadimed Corporation	-0.57%	79.69%	16.99%	75.37%	-37.53%	102.68%	-2.48%	-4.42%	61.45%	36.49%
SYK Stryker Corporation	-6.03%	-1.48%	21.34%	23.80%	-7.42%	10.22%	18.17%	35.33%	2.43%	30.84%

Fundamentals

Market Cap IRMD : $1.24B SYK : $127.31B
EPS IRMD : $1.75 SYK : $8.40
PE Ratio IRMD : 55.21 SYK : 39.22
PEG Ratio IRMD : 2.31 SYK : 2.24
PS Ratio IRMD : 14.81 SYK : 5.07
PB Ratio IRMD : 13.14 SYK : 2.66
Total Revenue (TTM) IRMD : $83.81M SYK : $25.12B
Gross Profit (TTM) IRMD : $64.32M SYK : $15.91B
EBITDA (TTM) IRMD : $28.93M SYK : $5.67B

Returns By Period

In the year-to-date period, IRMD achieves a -0.57% return, which is significantly higher than SYK's -6.03% return. Over the past 10 years, IRMD has outperformed SYK with an annualized return of 18.51%, while SYK has yielded a comparatively lower 12.99% annualized return.

IRMD

• 1D: 0.29%
• 1M: -6.94%
• YTD: -0.57%
• 6M: 38.35%
• 1Y: 83.29%
• 3Y*: 36.74%
• 5Y*: 33.43%
• 10Y*: 18.51%

SYK

• 1D: 0.25%
• 1M: -14.66%
• YTD: -6.03%
• 6M: -9.07%
• 1Y: -10.91%
• 3Y*: 5.91%
• 5Y*: 7.38%
• 10Y*: 12.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

IRMD vs. SYK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IRMD

IRMD Risk / Return Rank: 94
IRMD Sharpe Ratio Rank: 92
IRMD Sortino Ratio Rank: 94
IRMD Omega Ratio Rank: 91
IRMD Calmar Ratio Rank: 98
IRMD Martin Ratio Rank: 97

SYK

SYK Risk / Return Rank: 18
SYK Sharpe Ratio Rank: 19
SYK Sortino Ratio Rank: 18
SYK Omega Ratio Rank: 18
SYK Calmar Ratio Rank: 22
SYK Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IRMD vs. SYK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IRMD	SYK	Difference
Sharpe ratio Return per unit of total volatility	2.30	-0.48	+2.79
Sortino ratio Return per unit of downside risk	3.45	-0.57	+4.02
Omega ratio Gain probability vs. loss probability	1.42	0.93	+0.49
Calmar ratio Return relative to maximum drawdown	8.97	-0.57	+9.53
Martin ratio Return relative to average drawdown	22.88	-1.30	+24.19
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IRMD vs. SYK - Sharpe Ratio Comparison

The current IRMD Sharpe Ratio is 2.30, which is higher than the SYK Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of IRMD and SYK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	IRMD	SYK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.30	-0.48	+2.79
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.77	0.31	+0.46
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.50	-0.12
Sharpe Ratio (All Time) Calculated using the full available price history	0.44	0.57	-0.13

Correlation

The correlation between IRMD and SYK is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

IRMD vs. SYK - Dividend Comparison

IRMD's dividend yield for the trailing twelve months is around 1.25%, more than SYK's 1.04% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IRMD IRadimed Corporation	1.25%	1.21%	0.82%	3.54%	3.53%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SYK Stryker Corporation	1.04%	0.97%	0.90%	1.02%	1.16%	0.97%	0.96%	1.02%	1.23%	1.13%	1.31%	1.52%

Drawdowns

IRMD vs. SYK - Drawdown Comparison

The maximum IRMD drawdown since its inception was -75.83%, which is greater than SYK's maximum drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for IRMD and SYK.

Drawdown Indicators

	IRMD	SYK	Difference
Max Drawdown Largest peak-to-trough decline	-75.83%	-58.63%	-17.20%
Max Drawdown (1Y) Largest decline over 1 year	-9.67%	-18.80%	+9.13%
Max Drawdown (5Y) Largest decline over 5 years	-49.38%	-31.68%	-17.70%
Max Drawdown (10Y) Largest decline over 10 years	-64.30%	-43.80%	-20.50%
Current Drawdown Current decline from peak	-8.15%	-17.76%	+9.61%
Average Drawdown Average peak-to-trough decline	-28.28%	-13.07%	-15.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.79%	8.18%	-4.39%

Volatility

IRMD vs. SYK - Volatility Comparison

IRadimed Corporation (IRMD) has a higher volatility of 8.64% compared to Stryker Corporation (SYK) at 7.46%. This indicates that IRMD's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IRMD	SYK	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.64%	7.46%	+1.18%
Volatility (6M) Calculated over the trailing 6-month period	22.90%	15.63%	+7.27%
Volatility (1Y) Calculated over the trailing 1-year period	36.39%	22.58%	+13.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.62%	23.74%	+19.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.45%	26.06%	+23.39%

Financials

IRMD vs. SYK - Profitability Comparison

The chart below illustrates the profitability comparison between IRadimed Corporation and Stryker Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

IRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, IRadimed Corporation reported a gross profit of 17.03M and revenue of 22.69M. Therefore, the gross margin over that period was 75.1%.

SYK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Stryker Corporation reported a gross profit of 4.63B and revenue of 7.17B. Therefore, the gross margin over that period was 64.5%.

IRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, IRadimed Corporation reported an operating income of 7.09M and revenue of 22.69M, resulting in an operating margin of 31.3%.

SYK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Stryker Corporation reported an operating income of 1.80B and revenue of 7.17B, resulting in an operating margin of 25.2%.

IRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, IRadimed Corporation reported a net income of 6.44M and revenue of 22.69M, resulting in a net margin of 28.4%.

SYK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Stryker Corporation reported a net income of 849.00M and revenue of 7.17B, resulting in a net margin of 11.8%.